185 related articles for article (PubMed ID: 25994508)
1. CAPN5 mutation in hereditary uveitis: the R243L mutation increases calpain catalytic activity and triggers intraocular inflammation in a mouse model.
Wert KJ; Bassuk AG; Wu WH; Gakhar L; Coglan D; Mahajan M; Wu S; Yang J; Lin CS; Tsang SH; Mahajan VB
Hum Mol Genet; 2015 Aug; 24(16):4584-98. PubMed ID: 25994508
[TBL] [Abstract][Full Text] [Related]
2. Functional validation of a human CAPN5 exome variant by lentiviral transduction into mouse retina.
Wert KJ; Skeie JM; Bassuk AG; Olivier AK; Tsang SH; Mahajan VB
Hum Mol Genet; 2014 May; 23(10):2665-77. PubMed ID: 24381307
[TBL] [Abstract][Full Text] [Related]
3. Structural modeling of a novel CAPN5 mutation that causes uveitis and neovascular retinal detachment.
Bassuk AG; Yeh S; Wu S; Martin DF; Tsang SH; Gakhar L; Mahajan VB
PLoS One; 2015; 10(4):e0122352. PubMed ID: 25856303
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic variance in Calpain-5 retinal degeneration.
Tang PH; Chemudupati T; Wert KJ; Folk JC; Mahajan M; Tsang SH; Bassuk AG; Mahajan VB
Am J Ophthalmol Case Rep; 2020 Jun; 18():100627. PubMed ID: 32274441
[TBL] [Abstract][Full Text] [Related]
5. Photoreceptor Cell-Derived CAPN5 Regulates Retinal Pigment Epithelium Cell Proliferation Through Direct Regulation of SLIT2 Cleavage.
Wang Y; Li H; Zang S; Li F; Chen Y; Zhang X; Song Z; Peng Q; Gu F
Invest Ophthalmol Vis Sci; 2018 Apr; 59(5):1810-1821. PubMed ID: 29610848
[TBL] [Abstract][Full Text] [Related]
6. Two Novel CAPN5 Variants Associated with Mild and Severe Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy Phenotypes.
Randazzo NM; Shanks ME; Clouston P; MacLaren RE
Ocul Immunol Inflamm; 2019; 27(5):693-698. PubMed ID: 29040051
[No Abstract] [Full Text] [Related]
7. Lymphocyte infiltration in CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy.
Mahajan VB; Lin JH
Clin Ophthalmol; 2013; 7():1339-45. PubMed ID: 23861576
[TBL] [Abstract][Full Text] [Related]
8. CAPN5 gene silencing by short hairpin RNA interference.
Nelson NG; Skeie JM; Muradov H; Rowell HA; Seo S; Mahajan VB
BMC Res Notes; 2014 Sep; 7():642. PubMed ID: 25216694
[TBL] [Abstract][Full Text] [Related]
9. CAPN5 genetic inactivation phenotype supports therapeutic inhibition trials.
Wert KJ; Koch SF; Velez G; Hsu CW; Mahajan M; Bassuk AG; Tsang SH; Mahajan VB
Hum Mutat; 2019 Dec; 40(12):2377-2392. PubMed ID: 31403230
[TBL] [Abstract][Full Text] [Related]
10. Monozygotic twins with CAPN5 autosomal dominant neovascular inflammatory vitreoretinopathy.
Rowell HA; Bassuk AG; Mahajan VB
Clin Ophthalmol; 2012; 6():2037-44. PubMed ID: 23271883
[TBL] [Abstract][Full Text] [Related]
11. Early Onset Neovascular Inflammatory Vitreoretinopathy Due to a
O'Keefe G; Hanif AM; Mahajan VB; Jain N
Ocul Immunol Inflamm; 2019; 27(5):706-708. PubMed ID: 30986125
[TBL] [Abstract][Full Text] [Related]
12. Calpain-5 mutations cause autoimmune uveitis, retinal neovascularization, and photoreceptor degeneration.
Mahajan VB; Skeie JM; Bassuk AG; Fingert JH; Braun TA; Daggett HT; Folk JC; Sheffield VC; Stone EM
PLoS Genet; 2012; 8(10):e1003001. PubMed ID: 23055945
[TBL] [Abstract][Full Text] [Related]
13. Autosomal dominant neovascular inflammatory vitreoretinopathy with CAPN5 c.731T > C gene mutation; clinical management of a family cohort and review of the literature.
Tabbaa T; Mehra AA; Kesav NP; Mahajan VB; Swanson RD; Zubricky R; Sobol WM
Ophthalmic Genet; 2023 Dec; 44(6):559-567. PubMed ID: 37782277
[TBL] [Abstract][Full Text] [Related]
14. Capn5 Expression in the Healthy and Regenerating Zebrafish Retina.
Coomer CE; Morris AC
Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3643-3654. PubMed ID: 30029251
[TBL] [Abstract][Full Text] [Related]
15. Small-angle X-ray scattering of calpain-5 reveals a highly open conformation among calpains.
Gakhar L; Bassuk AG; Velez G; Khan S; Yang J; Tsang SH; Mahajan VB
J Struct Biol; 2016 Dec; 196(3):309-318. PubMed ID: 27474374
[TBL] [Abstract][Full Text] [Related]
16. Proteomic insight into the pathogenesis of CAPN5-vitreoretinopathy.
Velez G; Yang J; Li AS; Tsang SH; Bassuk AG; Mahajan VB
Sci Rep; 2019 May; 9(1):7608. PubMed ID: 31110225
[TBL] [Abstract][Full Text] [Related]
17. Impaired activity and membrane association of most calpain-5 mutants causal for neovascular inflammatory vitreoretinopathy.
Geddes JW; Bondada V; Croall DE; Rodgers DW; Gal J
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166747. PubMed ID: 37207905
[TBL] [Abstract][Full Text] [Related]
18. Early-onset Neovascular Inflammatory Vitreoretinopathy Due to Two de Novo CAPN5 Mutations in Chinese Patients: A Case Series.
Xia FJ; Lyu J; Zhang X; Fei P; Zhao PQ
Ocul Immunol Inflamm; 2023 Nov; 31(9):1777-1784. PubMed ID: 36369866
[TBL] [Abstract][Full Text] [Related]
19. Ultra-widefield Fluorescein Angiography and OCT Findings in Children and Young Adults with Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV).
Ebert JJ; Maccora I; Sapp CC; Nguyen T; Sisk RA; Srivastava SK; Angeles-Han ST; Sood AB
Ophthalmol Retina; 2024 May; ():. PubMed ID: 38782117
[TBL] [Abstract][Full Text] [Related]
20. An anti-CAPN5 intracellular antibody acts as an inhibitor of CAPN5-mediated neuronal degeneration.
Wang Y; Zhang X; Song Z; Gu F
Oncotarget; 2017 Nov; 8(59):100312-100325. PubMed ID: 29245980
[No Abstract] [Full Text] [Related]
[Next] [New Search]